Literature DB >> 3451230

Acyclovir treatment of herpes simplex encephalitis: experience in a district hospital.

M C Gulliford1, C P Chandrasekera, R A Cooper, R P Murphy.   

Abstract

Herpes simplex encephalitis may be underdiagnosed in Britain. We report eight patients treated at one hospital over three years. Fever, impaired consciousness or focal neurological signs were seen in all patients at presentation but herpes simplex encephalitis was rarely considered as the initial diagnosis. The electroencephalogram was the only initial investigation that was abnormal in each case and was the most useful test in establishing a clinical diagnosis. The diagnosis was confirmed by laboratory methods in each case. Following acyclovir treatment five patients were able to resume normal activities, one patient has moderate disability and two patients died. Three patients showed clinical evidence of relapse but two improved after further treatment with acyclovir. Herpes simplex encephalitis is a treatable condition and should be considered in all patients presenting with fever and neurological signs. The electroencephalogram is usually abnormal and the changes may be characteristic of the condition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3451230      PMCID: PMC2428572          DOI: 10.1136/pgmj.63.746.1037

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

1.  Herpes simplex virus encephalitis in children.

Authors:  E M Brett
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

2.  The electroencephalogram in herpes-simplex encephalitis.

Authors:  L S Illis; F M Taylor
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

3.  Rapid non-invasive diagnosis of herpes encephalitis.

Authors:  P E Klapper; I Laing; M Longson
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

4.  Herpes simplex encephalitis. Clinical Assessment.

Authors:  R J Whitley; S J Soong; C Linneman; C Liu; G Pazin; C A Alford
Journal:  JAMA       Date:  1982-01-15       Impact factor: 56.272

5.  Computerized tomography in brain biopsy-proven herpes simplex encephalitis. Early normal results.

Authors:  S B Greenberg; L Taber; E Septimus; S Kohl; J Puck; R N Bryan
Journal:  Arch Neurol       Date:  1981-01

6.  The clinical management of suspected herpes virus encephalitis. A decision-analytic view.

Authors:  P Braun
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

7.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

8.  Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance.

Authors:  A J Nahmias; R J Whitley; A N Visintine; Y Takei; C A Alford
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

9.  Relapsing herpes simplex encephalitis following antiviral therapy.

Authors:  L E Davis; L C McLaren
Journal:  Ann Neurol       Date:  1983-02       Impact factor: 10.422

10.  Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment.

Authors:  R D Dix; J R Baringer; H S Panitch; S H Rosenberg; J Hagedorn; J Whaley
Journal:  Ann Neurol       Date:  1983-02       Impact factor: 10.422

View more
  3 in total

1.  Unusual course of herpes simplex virus encephalitis after acyclovir therapy.

Authors:  W Preiser; B Weber; G Klös; P A Fischer; H W Doerr
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

Review 2.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 3.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.